bicalutamide 50mg tablets
torrent pharma (uk) ltd - bicalutamide - oral tablet - 50mg
bicalutamide tablet
remedyrepack inc. - bicalutamide (unii: a0z3nau9dp) (bicalutamide - unii:a0z3nau9dp) - bicalutamide tablets 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (lhrh) analog for the treatment of stage d 2 metastatic carcinoma of the prostate. bicalutamide tablets 150 mg daily is not approved for use alone or with other treatments [see clinical studies (14.2)]. bicalutamide is contraindicated in: - hypersensitivity bicalutamide is contraindicated in any patient who has shown a hypersensitivity reaction to the drug or any of the tablet’s components. hypersensitivity reactions including angioneurotic edema and urticaria have been reported. - women bicalutamide has no indication for women, and should not be used in this population. - pregnancy bicalutamide can cause fetal harm when administered to a pregnant woman [see us
bicalutamide fair-med 50mg film-coated tablets
fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - bicalutamide - film-coated tablet - bicalutamide 50 mg - endocrine therapy
phl-bicalutamide tablet
pharmel inc - bicalutamide - tablet - 50mg - bicalutamide 50mg - antineoplastic agents
nu-bicalutamide tablet
nu-pharm inc - bicalutamide - tablet - 50mg - bicalutamide 50mg - antineoplastic agents
ntp-bicalutamide tablet
teva canada limited - bicalutamide - tablet - 50mg - bicalutamide 50mg - antineoplastic agents
enzalutamide rowex 40 mg film-coated tablets
rowex ltd - enzalutamide - film-coated tablet - enzalutamide
enzalutamide rowex 80 mg film-coated tablets
rowex ltd - enzalutamide - film-coated tablet - enzalutamide
bicalutamide 150mg tablets
a a h pharmaceuticals ltd - bicalutamide - oral tablet - 150mg
bicalutamide 150mg tablets
alliance healthcare (distribution) ltd - bicalutamide - oral tablet - 150mg